glp 1 bebible Oral GLP-1 Medication Helps Patients Maintain Weight Loss | Newsroom GLP-1 Daily Support - Watermelon

et al., JAMA Ophthalmol

Call Soboba Weight Loss Today Disclaimer: Results may vary from person to person

Dosing Protocol Retatrutide was administered as a once-weekly subcutaneous injection with a carefully designed titration schedule to minimize side effects: Weeks 1-4: 2mg Weeks 5-8: 4mg Weeks 9-12: 6mg Weeks 13-16: 9mg (for 9mg group) or continue to 9mg (for 12mg group) Week 17+: 9mg maintenance (9mg group) or 12mg maintenance (12mg group) This gradual dose escalation over 12-16 weeks helped participants build tolerance to the medication's gastrointestinal effects while the therapeutic benefits accumulated

For comparison, semaglutide at the 2.4mg weekly dose used in the STEP trials produced average weight loss of approximately 15 percent of body weight over 68 weeks

Kumarathurai P, Anholm C, Larsen BS, et al

Native GLP-1 is degraded within minutes